NCT05285332View on ClinicalTrials.gov

Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy

NANot yet recruitingINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

December 31, 2030

Study Completion Date

May 1, 2031

Conditions
Breast NeoplasmsTreatmentMetastatic Breast CancerSurvival
Interventions
PROCEDURE

surgical treatment 1

Mastectomy OR Breast conserving surgery

PROCEDURE

surgical treatment 2

Resection of metastasis

DRUG

Systemic therapy

Endocrine therapy or chemotherapy or targeted therapy

All Listed Sponsors
lead

Changhai Hospital

OTHER

NCT05285332 - Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy | Biotech Hunter | Biotech Hunter